## AVY: Avery Dennison Corporation - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_20 -0.3% below STRENGTH zone (4.0-10.0%); PEG 1.76 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($167.37)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 1
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Bear of the Day: AptarGroup (ATR)**
- Source: Finviz | 20251209T110832 | Neutral | Relevance: 70%
-  AptarGroup (ATR) has been identified as the "Bear of the Day" due to its underperformance and struggles within the Containers-Paper and Packaging Industry. The company faces headwinds such as legal costs, inventory challenges, analyst downgrades, and weaker demand in healthcare markets, leading to declining EPS estimates and an unfavorable valuation compared to its peers. Despite consistent operational performance, concerns over its premium valuation relative to industry challenges suggest further downside risk for investors.

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 51.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 13.4% (+3.6%)
- Blackrock Inc.: 8.2% (-4.6%)
- Wellington Managemen: 7.5% (+12.5%)
- State Street Corpora: 4.7% (+0.6%)
- T. Rowe Price Invest: 4.3% (-7.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.76 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 30%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $13.6B |
| Beta | 1.01 |
| 52W Range | $156.23 - $206.45 |
| Short Interest | 2.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.76 |
| Forward P/E | 16.7 |
| Current P/E | 18.5 |
| YoY Growth | 10.8% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -2.0% to -0.3% (+1.7% in 5 days), confirming momentum buildup. Below STRENGTH zone by 4.3pp (needs >4.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.55), confirming momentum. RSI neutral at 55. Elevated volume (1.4x 20MA), institutional activity likely.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.29% (CS: 56) | Neutral |
| RSI_14 | 55.2 | Neutral |
| MACD Histogram | 0.55 | Bullish |
| vs SMA20 | 1.017x | Above |
| vs SMA50 | 1.033x | Above |
| vs SMA200 | 1.009x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $175.31
- **Stop Loss:** $167.37 (4.5% risk)
- **Target:** $183.25 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 62
- **Position Value:** $10,869.22
- **Portfolio %:** 10.87%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-01-29 (Est: $2.41)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.33 | $2.37 | +1.9% |
| 2025Q2 | $2.39 | $2.42 | +1.1% |
| 2025Q1 | $2.32 | $2.30 | -0.7% |
| 2024Q4 | $2.41 | $2.38 | -1.3% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*